UBS analyst Brennan Hawken downgraded Ameriprise (AMP) to Neutral from Buy with a price target of $570, down from $580. The firm says its re-rating thesis has played out with the stock now trading in-line with peers on fiscal 2026 estimates. UBS also sees less loan growth upside for Ameriprise as the company’s lending offering has seen slower adoption of financial advisors.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener